PAVmed Inc. (PAVM): Expected earnings per share growth for next year

Public company logo of PAVmed, Inc. (PAVM)

PAVmed Inc. revenues are growing through the commercialization of EsoGuard tests. The company is expanding its influence via clinic partnerships and patent acquisitions. The expected earnings per share growth rate in the GURU.Markets system reflects a trend where the indicator remains around 45.60. Its status as a diversified incubator and its unique esophageal cancer screening provide the issuer with complete pricing power.

PAVmed Inc. (PAVM): Consensus forecast of earnings per share growth for next year from 07/04/2022 to 11/14/2026

Analytical breakdowns for PAVmed Inc.

- price and consensus price forecast:
Price Chart PAVmed, Inc.|PAVM - Average Forecast Price
- stock exchange capitalization data:
Market Valuation PAVmed|PAVM - Enterprise Value
- book capitalization information:
Net Assets per Single Share PAVmed|PAVM - Book Valuation of Business|Market Cap to Net Assets Ratio pavmed.com|PAVM - Aggregate Asset Value
- debt and liquidity details:
Debt to Equity PAVmed Inc.|PAVM - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital PAVmed, Inc.|PAVM - Company Cumulative Debt|Debts to Book Capitalization PAVmed|PAVM - Company Long-Term Indebtedness|Company Short-Term Debts PAVmed|Quick Ratio pavmed.com
- net income and valuation ratios data:
PAVM - Net Income|Projected Future Earnings PAVmed Inc.|PAVM - P/E Multiple|Future Price to Earnings PAVmed, Inc.|PAVM - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio PAVmed|PAVM - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) PAVmed|PAVM - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months pavmed.com|PAVM - Net earnings per share change in current year|Expected earnings per share growth for next year PAVmed Inc.
- revenue and sales details:
PAVM - Revenue and Sales Volume|Projected Sales Volume PAVmed, Inc.|PAVM - Price-to-Revenue Coefficient|Price-to-Projected Revenue Ratio PAVmed
Fundamental company analysis:PAVmed Inc., PAVM
Core merchandise of PAVmed

This indicator measures the expected percentage growth in earnings per share, reflecting the analysts' consensus forecast regarding the future profitability of the business. Given the stable supply chains and ethical safeguards of PAVmed Inc. medical developments, this chart of analyst EPS growth estimates serves as a tool for assessing the company's strategic potential, allowing investors to optimize their portfolios in a timely manner based on fundamental trends.

Competing companies

Net earnings per share growth forecast for next year Stryker Inc|Expected net earnings per share growth next year Medtronic Corp MDT|Expected earnings per share growth for next year PHG (Koninklijke Philips N.V.)|Earnings growth forecast for next year smith-nephew.com (SNN)|Net earnings per share growth forecast for next year Hologic HOLX|Consensus forecast of earnings per share growth for next year Carlisle Companies Incorporated (CSL)|ITGR: Expected earnings per share growth for next year|Expected earnings per share trend next year LIVN (LivaNova Corp)|AdaptHealth Corp. (AHCO) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year SS Innovations|AVNS (Avanos Medical) - Earnings growth forecast for next year|Expected net earnings per share growth next year Shoulder Innovations Inc SI|Earnings growth forecast for next year VMD|inogen.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year OWLT (Owlet)|Consensus forecast of earnings per share growth for next year quipthomemedical.com (QIPT)|Precision Optics Corporation, Inc. - Earnings growth forecast for next year|Tivic Health Systems, Inc. (TIVC) - Expected earnings per share growth for next year|MOVE: Earnings growth forecast for next year|Nuvo Group Ltd (NUVO) - Earnings growth forecast for next year